Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Policy Would Harmonize Health Claims, Grant Proprietary Rights – Lawyer

This article was originally published in The Tan Sheet

Executive Summary

A directive that is under consideration by the European Union to harmonize health claims across member states would grant proprietary rights to claims that are substantiated by original research, according to Attorney Nicole Coutrelis

You may also be interested in...



EU Nutrition, Health Claim Reg Would Establish Approved-Claims Registry

Health claims referring to "children's development and health" will undergo a more stringent authorization process in the EU than other non-disease-risk-reduction claims, according to regulatory language adopted by the European Parliament May 16

EU Nutrition, Health Claim Reg Would Establish Approved-Claims Registry

Health claims referring to "children's development and health" will undergo a more stringent authorization process in the EU than other non-disease-risk-reduction claims, according to regulatory language adopted by the European Parliament May 16

EU Nutrition, Health Claim Reg Would Establish Approved-Claims Registry

Health claims referring to "children's development and health" will undergo a more stringent authorization process in the EU than other non-disease-risk-reduction claims, according to regulatory language adopted by the European Parliament May 16

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099259

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel